Hemlibra 105mg Injection

Name: Hemlibra 105mg Injection
Brand: ROCHE PRODUCTS INDIA PVT LTD
SKU: MRM_103545
Price: 290306 INR
Availability: InStock

New

Brand: ROCHE PRODUCTS INDIA PVT LTD

Product Code: MRM_103545

Reviews: (0)

In Stock

₹290 306

Found this product cheaper?

Specifications: (see all)

Manufacturer

ROCHE PRODUCTS INDIA PVT LTD

Origin of Medicine

Switzerland

Price for

1 Vial(s)

Salt Composition

Emicizumab

Delivery Delivery from India within 15 days. Payment Pay quickly and conveniently Cumulative discounts Collect bonuses and gifts

Hemlibra 105mg Injection contains the active constituent Emicizumab. It belongs to the class of medications called monoclonal antibodies. It is used to treat patients with r hemophilia A who have developed factor VIII inhibitors. It is also indicated to treat severe hemophilia A who have not developed factor VIII inhibitors (the FVIII blood level is less than 1%).

Haemophilia A is an inherited condition caused by a lack of factor VIII, an essential substance required for blood to clot and stop bleeding. Monoclonal antibodies are a type of protein that recognize and bind to a target in the body. The medicine prevents bleeding or reduces bleeding episodes in people with this condition.

Do not take Hemlibra 105mg Injection if you are allergic to Emicizumab or any other ingredients. Before you start using this medicine, it is very important to talk to your doctor about using any other medications. Inform your physician immediately if bleeding occurs after taking this medicine. This medicine is used in all age groups. Do not give this injection where the skin is red, bruised, tender, hard, or areas where there are moles or scars

Uses of Hemlibra 105mg Injection

Hemophilia A

Therapeutic Effects of Hemlibra 105mg Injection

Hemlibra 105mg Injection binds to activated factor IX and factor X to restore function to the coagulation cascade and promote hemostasis. It restores the function of missing activated factor VIII, which is needed for effective blood clotting. Its structure differs from factor VIII; therefore, the medicine is unaffected by factor VIII inhibitors.

Interaction of Hemlibra 105mg Injection with other drugsInform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, nutritional and vitamin supplements, and herbal products. Certain medications interact with Hemlibra 105mg Injection and reduce its effectiveness by causing undesirable side effects.

More Information about Hemlibra 105mg Injection

Store in a refrigerator (2°C to 8°C)

Do not freeze

Protect the medicine from light and excessive moisture.

Keep the medicine out of reach of children and pets

If you missed the dosing schedule, inform your healthcare professional immediately and reschedule.

How to consume Hemlibra 105mg InjectionHemlibra 105mg Injection will be given by injection under the skin (subcutaneous). Your doctor or nurse or other healthcare professional will show you how to inject the medicine. Do not try to administer the medicine if you are well-trained. Your physician will decide the dose of the injection based on your disease condition and severity.

The recommended places to give an injection are the front of the waist (lower abdomen), upper outer arms, or the front of the thighs. Use only recommended places for injection. ● For each injection, use a different area of the body than the one you used last time.

Safety Advices for Hemlibra 105mg Injection

Pregnancy

Do not take Hemlibra 105mg Injection if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting pregnancy, or planning to get pregnant during the treatment. Use effective contraception during the treatment and for 6 months after the last dose.

Breast Feeding

Breastfeeding is not recommended in patients taking Hemlibra 105mg Injection because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.

Lungs

It is unknown whether Hemlibra 105mg Injection can be used in patients with lung disorders. Consult your doctor if you have any lung diseases before starting the treatment.

Liver

It is safe to administer Hemlibra 105mg Injection in patients with liver problems. No dose adjustments are needed for mild to moderate impairment. However, Inform your physician if you have any liver diseases before initiating the treatment.

Alcohol

It is unknown whether it is safe to consume alcohol with Hemlibra 105mg Injection. Inform your physician if you are a chronic drinker.

Driving

Hemlibra 105mg Injection does not affect your ability to drive and operate heavy machinery. Inform your physician if you face any symptoms that alter your concentration.

Side Effects of Hemlibra 105mg InjectionSide effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Common

Injection site reactions
Joint pain
Headache

Serious

Heart problems
Muscle cramps and pain
Blood clot
Bleeding
Destruction of red blood cells

Word of AdviceThis medicine is given as a shot under your skin. It is usually injected into the upper outer arms, thighs, or stomach. Use a different body area each time you give yourself a shot. Keep track of where you give each shot to make sure you rotate body areas. Do not inject into skin areas that are tender, red, bruised, hard, or not intact, or into areas with moles or scars. Use a new needle and syringe each time you inject your medicine.

Women should use an effective form of birth control to keep from getting pregnant. Tell your doctor right away if you think you have become pregnant. Your doctor will do lab tests at regular visits to check on the effects of this medicine. Keep all appointments

FAQs Q 1. Can Hemlibra 105mg Injection be self-administered at home?

Yes, Hemlibra 105mg Injection can be self-administered at home after proper training and instructions from a healthcare professional. However, the decision to self-administer should be made in consultation with the healthcare team.

Q 2. Can Hemlibra 105mg Injection be used in pediatric patients with hemophilia?

Yes, Hemlibra 105mg Injection is approved for use in pediatric patients with hemophilia A. The dosage and administration may vary depending on the age and weight of the child, and it should be prescribed and monitored by a healthcare professional.

Q 3. Is Hemlibra 105mg Injection suitable for all types of hemophilia?

Hemlibra 105mg Injection is specifically designed for the treatment of hemophilia A, which is caused by a deficiency of clotting factor VIII. It is not intended for other types of hemophilia, such as hemophilia B.

Q 4. How is Hemlibra 105mg Injection administered?

Hemlibra 105mg Injection is administered as a subcutaneous injection, generally, it is given once a week, every two weeks, or every four weeks, depending on the treatment plan determined by the healthcare provider. The frequency of the administration depends on your disease condition and other factors.

Q 5. What should I inform the physician before starting the treatment with Hemlibra 105mg Injection?

Before you start using Hemlibra 105mg Injection, talk to your doctor and carefully follow their instructions on when to use a bypassing agent and the dose and schedule you should use. It increases the ability of your blood to clot. Therefore, the dose of bypassing agent required may be lower than the dose you used before starting Hemlibra.

Fact Box of Hemlibra 105mg Injection

Molecule name: Emicizumab	Therapeutic class: Antihemophilic agent
Pharmacological class: Bispecific monoclonal antibody	Indications: Hemophilia A

Основные характеристики

Manufacturer

ROCHE PRODUCTS INDIA PVT LTD

Origin of Medicine

Switzerland

Price for

1 Vial(s)

Salt Composition

Emicizumab

Reviews

0/ 5

average product rating

There are no reviews for this product. Be the first to leave your review.